It is not intended for use in diagnostic procedures, therapeutic applications, or in vivo studies of any kind
Orforglipron met ATTAIN-1s primary endpoint by lowering weight by an average of 12.4% (27.3 lbs) vs
The binding of folic acid to proteins, such as whey protein isolate, casein, -lactoglobulin, -lactalbumin, and bovine serum albumin decreased folic acid losses due to photodegradation induced by ultraviolet radiation
Current Research Landscape and Clinical Translation Systematic Review of Evidence A 2024 systematic review examining BPC-157 use in orthopedic sports medicine identified 544 articles published between 1993 and 2024, with 36 studies meeting inclusion criteria for detailed analysis
doi: 10.4049/jimmunol.1700105 172 ZhuL.HanJ.LiL.WangY.LiY.ZhangS
(PubMed) Shinto L, Quinn J, Montine T, et al